Intraperitoneal pulse calcitriol in the treatment of secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis

Peritoneal Dialysis International

Volumn 18, Issue 2, 1998, Pages 177-182

  Chan, Hilda W H ^a   Tsang, Wai Kay ^a   Chan, Chor Man ^a   Fung, Samuel K S ^a   So, Sheung On ^a   Tang, Hon Lok ^a   Tong, Matthew K L ^a   Lee, Kam Cheong ^a   Chan, Albert Y W ^a  

^a PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

Intraperitoneal pulse calcitriol; Secondary hyperparathyroidism

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM ACETATE; CALCIUM CARBONATE; CALCIUM ION; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT; UREA;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; FOLLOW UP; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PERITONEAL CATHETER; PERITONEAL CAVITY; PERITONITIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; TIME; TREATMENT OUTCOME;

EID: 0031922215     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089801800206     Document Type: Article

References (21)

1. Martin KJ, Ballal HS, Domoto DT, Blalock S, Weindel M. Pulse oral calcitriol for the treatment of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis: preliminary observations. Am J Kidney Dis 1992; 19:540-5.
2. Coburn JW. Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy. Kidney Int 1990; 38(Suppl 29):S54-61.
3. 3 pulse therapy in hemodialysis patients with severe secondary hyperparathyroidism. Nephron 1991; 57:23-8.
4. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984; 74:2136-43.
5. Norris KC, Kraut JA, Andress DL, Agre KL, Sherrard DJ, Coburn JW. Intravenous calcitriol: effects in severe secondary hyperparathyroidism. J Bone Miner Res 1986; 1(Suppl 1):374.
6. Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 1989; 321:274-9.
7. Delmez JA, Tindira C, Grooms P, Dusso A, Windus DW, Slatopolsky E. Parathyroid suppression by intravenous 1,25-dihydroxyvitamin D: a role for increased sensitivity to calcium. J Clin Invest 1989; 83:1349-55.
8. Dunlay R, Rodriguez M, Felsenfeld AJ, Llach F. Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int 1989; 36:1093-8.
9. Gallieni M, Brancaccio D, Padovese P, Rolla D, Bedani P, Colantonio G, et al. Low dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Kidney Int 1992; 42:1191-8.
10. Cannella G, Bonucci E, Rolla D, Ballanti P, Moriero E, Grandi RD, et al. Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol. Kidney Int 1994; 46:1124-32.
11. Malberti F, Surian M, Cosci P. Improvement of secondary hyperparathyroidism and reduction of the set point of calcium after intravenous calcitriol. Kidney Int 1993; 43(Suppl 41):S125-30.
12. 3 in experimental renal hyperparathyroidism. Kidney Int 1993; 44:1259-65.
13. Arora N, Sandroni S, Moles K. Marked improvement in parameters of renal osteodystrophy with the use of intraperitoneal calcitriol. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1992; 8:62-4.
14. Delmez JA, Dougan CS, Gearing BK, Rothstein M, Windus DW, Rapp N, et al. The effects of intraperitoneal calcitriol on calcium and parathyroid hormone. Kidney Int 1987; 31:795-9.
15. Salusky IB, Goodman WG, Horst R, Segre GV, Kim L, Norris KC, et al. Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patients. Am J Kidney Dis 1990; 16(2):126-32.
16. Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, et al. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 1994; 46:1160-6.
17. Delmez JA, Kelber J, Tindira C, Norwood K, Giles K, Slatopolsky EA. Long term effects of early use of IV calcitriol in the prevention of secondary hyperparathyroidism in hemodialysis patients. J Am Soc Nephrol 1993; 4:695.
18. Kiernan L, Kliger A, Gorban-Brennan N, Juergensen P, Tesin D, Vonesh E, et al. Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems. J Am Soc Nephrol 1995; 5(10):1835-8.
19. Dasgupta MK, Fox S, Gagnon D, Bettcher K, Ulan RA. Significant reduction of peritonitis rate by the use of twin-bag system in a Canadian regional CAPD program. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1992; 8:223-6.
20. Llach F, Bover J. Renal osteodystrophy. In: Brenner BM, ed. The kidney. Hong Kong: W.B. Saunders, 1996:2187-203.
21. Fournier A, Yverneau PH, Hue P, Said S, Hamdini N, Eldin HM, et al. Adynamic bone disease in patients with uremia. Curr Opin Nephrol Hypertens 1994; 3:396-410.